ALIBREX

Welcome to the Brand page for “ALIBREX”, which is offered here for Medical diagnostic assays for testing of bodily fluids, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy;medical testing for diagnostic or treatment purposes, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy;medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy;.

Its status is currently believed to be active. Its class is unavailable. “ALIBREX” is believed to be currently owned by “Cadex Genomics, Corp.”